CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹267 Cr | ₹245 Cr | ₹265 Cr | ₹246 Cr | ₹207 Cr |
What is the latest Cash Flow from Operating Activities ratio of CONCORD BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹267 Cr |
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹265 Cr |
| Mar2023 | ₹246 Cr |
| Mar2022 | ₹207 Cr |
How is Cash Flow from Operating Activities of CONCORD BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹267 Cr | 9.15 | |
| Mar2025 | ₹245 Cr | -7.89 | |
| Mar2024 | ₹265 Cr | 7.91 | |
| Mar2023 | ₹246 Cr | 18.57 | |
| Mar2022 | ₹207 Cr | - | |
Compare Cash Flow from Operating Activities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,418.6 Cr | -6.2% | -12.3% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -6.2% |
-12.3% |
-14.6% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses